Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julia K. Neugebauer"'
Autor:
Bernadette A.S. Jäger, Charlotte Finkenzeller, Carolin Bock, Leonie Majunke, Julia K. Jueckstock, Ulrich Andergassen, Julia K. Neugebauer, Aurelia Pestka, Thomas W.P. Friedl, Udo Jeschke, Wolfgang Janni, Sophie F. Doisneau-Sixou, Brigitte K. Rack
Publikováno v:
Translational Oncology, Vol 8, Iss 6, Pp 509-516 (2015)
BACKGROUND: We evaluated both estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status on disseminated tumor cells (DTCs) in the bone marrow of 54 patients with early breast cancer and compared these with the corresponding pr
Externí odkaz:
https://doaj.org/article/b76ad74c8490456398f6deb59267e44b
Autor:
Knörle, Claudia, Becker, Valeska
Publikováno v:
Cheiron: The International Journal of Equine & Equestrian History; 2024, Vol. 4 Issue 1, p23-50, 28p
Autor:
Matthias W. Beckmann, Marianna Alunni-Fabbroni, Wolfgang Janni, Julia Neugebauer, Klaus Friese, Thomas Decker, Bernadette As Jaeger, Klaus Pantel, Tanja Fehm, Susanne Albrecht, C Melcher, Ralf Lorenz, Ulrich Andergassen, Peter A. Fasching, Georg Heinrich, Brigitte Rack, Thomas W. P. Friedl, Carsten Hagenbeck, Andreas Schneeweiss
Publikováno v:
Cancer Research. 75:P4-01
Background There is growing evidence that circulating tumor cells (CTCs) have prognostic impact in patients (pts) with early breast cancer (EBC). In this study the persistence of CTCs immediately after and two years after chemotherapy (Ctx) was prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::033bd0b18bf0fbe0e8f2169d9665439c
https://doi.org/10.1158/1538-7445.sabcs14-p4-01-08
https://doi.org/10.1158/1538-7445.sabcs14-p4-01-08